FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2096478712> ?p ?o ?g. }

• W2096478712 endingPage "1457" @default.
• W2096478712 startingPage "1446" @default.
• W2096478712 abstract "OBJECTIVE Increased plasma concentrations of apolipoprotein B100 often present in patients with insulin resistance and confer increased risk for the development of atherosclerosis. Naturally occurring polyphenolic compounds including flavonoids have antiatherogenic properties. The aim of the current study was to evaluate the effect of the polymethoxylated flavonoid nobiletin on lipoprotein secretion in cultured human hepatoma cells (HepG2) and in a mouse model of insulin resistance and atherosclerosis. RESEARCH DESIGN AND METHODS Lipoprotein secretion was determined in HepG2 cells incubated with nobiletin or insulin. mRNA abundance was evaluated by quantitative real-time PCR, and Western blotting was used to demonstrate activation of cell signaling pathways. In LDL receptor–deficient mice (Ldlr−/−) fed a Western diet supplemented with nobiletin, metabolic parameters, gene expression, fatty acid oxidation, glucose homeostasis, and energy expenditure were documented. Atherosclerosis was quantitated by histological analysis. RESULTS In HepG2 cells, activation of mitogen-activated protein kinase-extracellular signal–related kinase signaling by nobiletin or insulin increased LDLR and decreased MTP and DGAT1/2 mRNA, resulting in marked inhibition of apoB100 secretion. Nobiletin, unlike insulin, did not induce phosphorylation of the insulin receptor or insulin receptor substrate-1 and did not stimulate lipogenesis. In fat-fed Ldlr−/− mice, nobiletin attenuated dyslipidemia through a reduction in VLDL-triglyceride (TG) secretion. Nobiletin prevented hepatic TG accumulation, increased expression of Pgc1α and Cpt1α, and enhanced fatty acid β-oxidation. Nobiletin did not activate any peroxisome proliferator–activated receptor (PPAR), indicating that the metabolic effects were PPAR independent. Nobiletin increased hepatic and peripheral insulin sensitivity and glucose tolerance and dramatically attenuated atherosclerosis in the aortic sinus. CONCLUSIONS Nobiletin provides insight into treatments for dyslipidemia and atherosclerosis associated with insulin-resistant states." @default.
• W2096478712 created "2016-06-24" @default.
• W2096478712 creator A5000216881 @default.
• W2096478712 creator A5007768979 @default.
• W2096478712 creator A5014041017 @default.
• W2096478712 creator A5024168823 @default.
• W2096478712 creator A5037390890 @default.
• W2096478712 creator A5046009433 @default.
• W2096478712 creator A5067064393 @default.
• W2096478712 creator A5071725615 @default.
• W2096478712 creator A5076251127 @default.
• W2096478712 creator A5077211924 @default.
• W2096478712 creator A5078989315 @default.
• W2096478712 creator A5079937691 @default.
• W2096478712 creator A5090036346 @default.
• W2096478712 date "2011-04-23" @default.
• W2096478712 modified "2023-10-16" @default.
• W2096478712 title "Nobiletin Attenuates VLDL Overproduction, Dyslipidemia, and Atherosclerosis in Mice With Diet-Induced Insulin Resistance" @default.
• W2096478712 cites W169688439 @default.
• W2096478712 cites W1971082641 @default.
• W2096478712 cites W1972088904 @default.
• W2096478712 cites W1976359846 @default.
• W2096478712 cites W1978136788 @default.
• W2096478712 cites W1979811613 @default.
• W2096478712 cites W1982488301 @default.
• W2096478712 cites W1982621565 @default.
• W2096478712 cites W1991735443 @default.
• W2096478712 cites W1995392322 @default.
• W2096478712 cites W2019973807 @default.
• W2096478712 cites W2020659754 @default.
• W2096478712 cites W2021926309 @default.
• W2096478712 cites W2021976026 @default.
• W2096478712 cites W2022026458 @default.
• W2096478712 cites W2022542452 @default.
• W2096478712 cites W2023011167 @default.
• W2096478712 cites W2030568190 @default.
• W2096478712 cites W2031557719 @default.
• W2096478712 cites W2036569845 @default.
• W2096478712 cites W2053715322 @default.
• W2096478712 cites W2062769455 @default.
• W2096478712 cites W2084062672 @default.
• W2096478712 cites W2095612977 @default.
• W2096478712 cites W2102862906 @default.
• W2096478712 cites W2107822525 @default.
• W2096478712 cites W2118728926 @default.
• W2096478712 cites W2119361109 @default.
• W2096478712 cites W2120293566 @default.
• W2096478712 cites W2128519218 @default.
• W2096478712 cites W2129582474 @default.
• W2096478712 cites W2134604231 @default.
• W2096478712 cites W2135068351 @default.
• W2096478712 cites W2142415239 @default.
• W2096478712 cites W2144678546 @default.
• W2096478712 cites W2149024494 @default.
• W2096478712 cites W2149098343 @default.
• W2096478712 cites W2153302582 @default.
• W2096478712 cites W2153673527 @default.
• W2096478712 cites W2153688154 @default.
• W2096478712 cites W2158676408 @default.
• W2096478712 cites W2159216465 @default.
• W2096478712 cites W2163016231 @default.
• W2096478712 cites W2166292243 @default.
• W2096478712 cites W4252021281 @default.
• W2096478712 doi "https://doi.org/10.2337/db10-0589" @default.
• W2096478712 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3292317" @default.
• W2096478712 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21471511" @default.
• W2096478712 hasPublicationYear "2011" @default.
• W2096478712 type Work @default.
• W2096478712 sameAs 2096478712 @default.
• W2096478712 citedByCount "158" @default.
• W2096478712 countsByYear W20964787122012 @default.
• W2096478712 countsByYear W20964787122013 @default.
• W2096478712 countsByYear W20964787122014 @default.
• W2096478712 countsByYear W20964787122015 @default.
• W2096478712 countsByYear W20964787122016 @default.
• W2096478712 countsByYear W20964787122017 @default.
• W2096478712 countsByYear W20964787122018 @default.
• W2096478712 countsByYear W20964787122019 @default.
• W2096478712 countsByYear W20964787122020 @default.
• W2096478712 countsByYear W20964787122021 @default.
• W2096478712 countsByYear W20964787122022 @default.
• W2096478712 countsByYear W20964787122023 @default.
• W2096478712 crossrefType "journal-article" @default.
• W2096478712 hasAuthorship W2096478712A5000216881 @default.
• W2096478712 hasAuthorship W2096478712A5007768979 @default.
• W2096478712 hasAuthorship W2096478712A5014041017 @default.
• W2096478712 hasAuthorship W2096478712A5024168823 @default.
• W2096478712 hasAuthorship W2096478712A5037390890 @default.
• W2096478712 hasAuthorship W2096478712A5046009433 @default.
• W2096478712 hasAuthorship W2096478712A5067064393 @default.
• W2096478712 hasAuthorship W2096478712A5071725615 @default.
• W2096478712 hasAuthorship W2096478712A5076251127 @default.
• W2096478712 hasAuthorship W2096478712A5077211924 @default.
• W2096478712 hasAuthorship W2096478712A5078989315 @default.
• W2096478712 hasAuthorship W2096478712A5079937691 @default.
• W2096478712 hasAuthorship W2096478712A5090036346 @default.
• W2096478712 hasBestOaLocation W20964787121 @default.
• W2096478712 hasConcept C112446052 @default.

• next